Results 171 to 180 of about 5,863 (219)
Transient pain and long-term gain: adjuvant dose directs immune memory. [PDF]
J Clin InvestPal PB, Iyer SS.
europepmc +1 more source
A promising <i>Staphylococcus aureus</i> vaccine adjuvant candidate to overcome <i>Staphylococcal</i> infection based on innate immunity. [PDF]
Clin Exp Vaccine ResMao X +5 more
europepmc +1 more source
Humoral responses to Cytomegalovirus glycoprotein B vaccine with MF59 adjuvant
, 2017 openaire +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Vaccine, 2008
The need to enhance the immunogenicity of purified subunit antigens has prompted the development of new adjuvants. The adjuvant emulsion MF59 has been tested in animals in combination with different antigens and finally evaluated in humans. It was licensed after the successful outcome of preclinical and clinical testing.
Viola, Schultze +5 more
openaire +2 more sources
The need to enhance the immunogenicity of purified subunit antigens has prompted the development of new adjuvants. The adjuvant emulsion MF59 has been tested in animals in combination with different antigens and finally evaluated in humans. It was licensed after the successful outcome of preclinical and clinical testing.
Viola, Schultze +5 more
openaire +2 more sources
Antigenically Distinct MF59-Adjuvanted Vaccine to Boost Immunity to H5N1
New England Journal of Medicine, 2008The authors report on an open-label study of an MF59-adjuvanted vaccine against avian influenza.
Stephenson, I +8 more
openaire +3 more sources
Biodistribution and mechanisms of action of MF59 and MF59-like adjuvants
Journal of Controlled ReleaseRecently, adjuvants have received increasing attention as essential vaccine components. Nearly 100 years have passed since Gaston Roman introduced the concept of adjuvants in 1925, during which numerous preclinical and clinical studies related to vaccine adjuvants have been conducted.
Wen, Zhang +7 more
openaire +2 more sources
Mf59 ® -Adjuvanted Seasonalinfluenza Vaccine
Aging Health, 2009Correlated with increasing chronologic age, immunosenescence impairs the response to influenza vaccines. MF59®-adjuvanted influenza vaccine (Fluad®, Novartis, Basel, Switzerland) elicits a stronger and broader immune response against well-matched and drifted influenza strains compared with conventional vaccines. MF5-adjuvanted influenza vaccine reduces
openaire +1 more source
Vaccine, 2009
Adding adjuvants such as MF59((R)) to influenza vaccines can enhance the immune response. This analysis evaluated the safety profile of MF59-adjuvanted [(+)MF59] compared with non-adjuvanted [(-)MF59] vaccines in a large clinical database.Safety data were pooled from 64 clinical trials involving (+)MF59 seasonal and pandemic influenza vaccines.
Michele, Pellegrini +4 more
openaire +2 more sources
Adding adjuvants such as MF59((R)) to influenza vaccines can enhance the immune response. This analysis evaluated the safety profile of MF59-adjuvanted [(+)MF59] compared with non-adjuvanted [(-)MF59] vaccines in a large clinical database.Safety data were pooled from 64 clinical trials involving (+)MF59 seasonal and pandemic influenza vaccines.
Michele, Pellegrini +4 more
openaire +2 more sources